Organovo

$14.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.40 (+2.86%) Today
$0.00 (0.00%) As of 9:42 PM UTC after-hours

Why Robinhood?

You can buy or sell Organovo and other stocks, options, and ETFs commission-free!

About ONVO

Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded in April 2007 and is headquartered in San Diego, CA. The listed name for ONVO is Organovo Holdings, Inc. Common Stock.

CEO
Keith Murphy
Employees
6
Headquarters
San Diego, California
Founded
2012
Market Cap
90.44M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
428.46K
High Today
$15.37
Low Today
$14.02
Open Price
$14.12
Volume
343.85K
52 Week High
$20.49
52 Week Low
$3.87

Collections

ONVO Earnings

-$1.36
-$0.91
-$0.45
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Feb 18, After Hours

You May Also Like

SONN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure